NutriDex

The Supplement Research Compendium
🧫

Serrapeptase

Serratiopeptidase

Proteolytic enzyme marketed for inflammation, swelling and pain.

Mixed evidence ✨Joint & Skin

✚ Updated · How we grade evidence

Evidence tier
Mixed
Research weight
Citations
10 verified / 10
Classification
Joint & Skin
❝
What the evidence says. Graded mixed: individual RCTs report benefit for surgical trismus, breast engorgement and sputum clearance, but trials are small, often old, open-label or industry-linked, the best meta-analysis found benefit only for trismus (not pain or swelling), and a 2013 systematic review judged the evidence insufficient to recommend it. (Mixed evidence: Conflicting results across studies; benefit uncertain.)

What is Serrapeptase?

Serrapeptase (Serratiopeptidase) is a joint and skin supplement used for reduce post-surgical swelling. NutriDex grades the human evidence as Mixed. Serrapeptase is a proteolytic enzyme originally isolated from silkworm-gut bacteria (Serratia) and sold as an enteric-coated supplement for inflammation, swelling and mucus. Small randomized trials show some real but narrow effects: after impacted third-molar surgery it improved jaw opening and swelling versus placebo, and a 2023 meta-analysis of six trials confirmed a benefit for trismus but not for pain or swelling. Older RCTs report less breast engorgement (about 86% vs 60% improved) and thinner, more easily cleared sputum in chronic airway disease. Head-to-head, dexamethasone outperformed it for swelling and pain, and a 2026 study found no antifibrotic benefit after liposuction. Most trials are small, short, open-label or company-linked, and oral bioavailability is uncertain because the enzyme is a large, acid-sensitive protein. A 2013 systematic review concluded the evidence is too weak to recommend it.

Purported Benefits

✓Reduce post-surgical swelling
✓Ease jaw stiffness (trismus)
✓Thin and clear mucus
✓Anti-inflammatory adjunct

Evidence by outcome

The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.

OutcomeEvidenceEffectStudies
Ease jaw stiffness (trismus) post-surgeryMeta-analysis of 6 trials and an RCT (n=133) show reduced trismus after molar surgery. Moderate ↑ benefit · small 2
Reduce post-surgical pain/swellingMeta-analysis found no pain/swelling benefit; dexamethasone outperformed it; older breast trial positive. Mixed ↔ mixed · small 3
Thin and clear mucusSingle open-label RCT (n=29) reduced sputum viscosity and cough; no blinding. Preliminary ↑ benefit · moderate 1
General anti-inflammatory/analgesic useSystematic review judged evidence insufficient to recommend; trials poor quality, bioavailability uncertain. No Evidence ↔ mixed 1

Dosing & Compounds

Typical Dose
Commonly 10–60 mg/day (≈20,000–120,000 SPU) as enteric-coated tablets, taken on an empty stomach in 2–3 divided doses.
Active Compounds
Serratiopeptidase (a serine metalloprotease from Serratia E15)

Safety & Cautions

Generally well tolerated short-term; common effects are nausea, GI upset, skin rash and cough. Because it breaks down fibrin, it may add to bleeding risk with anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel, DOACs) and should be stopped before surgery; avoid in active abscess, as it can degrade the fibrin barrier and spread infection. Rare but serious reports include eosinophilic pneumonitis, bullous skin reactions and hemorrhage; long-term safety data are lacking and it is not recommended in pregnancy or breastfeeding given limited evidence. Educational only — always check with your doctor or pharmacist before combining Serrapeptase with any medicine.

Serrapeptase drug interactions

Known or theoretical interactions between Serrapeptase and common medications — educational, not exhaustive. Always check with your doctor or pharmacist before combining Serrapeptase with any medicine.

Caution
Blood thinners (warfarin, DOACs)
Serrapeptase may add to bleeding risk when taken with blood thinners.
Serratiopeptidase is a fibrinolytic protease that breaks down fibrin, compounding anticoagulant effects. Serratiopeptidase: therapeutic applications (review, PubMed)
Caution
Antiplatelet drugs (aspirin, clopidogrel)
Serrapeptase with aspirin or clopidogrel may increase bleeding tendency.
Its fibrinolytic and antithrombotic activity adds to platelet inhibition. Serratiopeptidase: therapeutic applications (review, PubMed)

Key Studies ★ 10 studies

Meta-analysis Arbildo-Vega 2023 ✓ Full text
Meta-analysis of 6 trials: serratiopeptidase reduced trismus after third-molar surgery but did NOT reduce postoperative pain or swelling.
Systematic review Bhagat 2013 ✓ PubMed
Systematic review: existing evidence judged insufficient to support serratiopeptidase as an analgesic or anti-inflammatory; trials had poor methodology and small samples.
RCT Tamimi 2021 ✓ PubMed
RCT (n=133): vs placebo, serratiopeptidase improved day-4 trismus (27.3 vs 32.1 mm interincisal) and swelling (P<0.001), but pain did not differ.
RCT Murugesan 2012 ✓ PubMed
RCT (n=110): dexamethasone was more effective than serratiopeptidase for swelling and pain after third-molar surgery; trismus control was similar.
RCT Kee 1989 ✓ PubMed
Double-blind RCT (n=70): for breast engorgement, 85.7% improved with serrapeptase vs 60.0% placebo (P<0.05).
RCT Nakamura 2003 ✓ Full text
Open-label RCT (n=29): 30 mg/day for 4 weeks reduced sputum weight, viscosity, elasticity and neutrophils, and cut cough and expectoration frequency.
RCT Panagariya 1999 ✓ PubMed
Preliminary open trial (n=20): 65% of carpal tunnel patients showed clinical and electrophysiological improvement; no placebo control.
Safety Rajaram 2016 ✓ PubMed
Case report: serratiopeptidase implicated in spread of a buccal-space abscess by degrading the fibrin wall that contains infection; caution advised with abscesses.
Cohort Heller 2026 ✓ PubMed
Cohort (n=50): 60,000 IU/day for 4 weeks after liposuction for lipedema showed no measurable antifibrotic benefit on ultrasound elastography or patient outcomes.
Review Jadhav 2020 ✓ PubMed
Review: notes anti-inflammatory and mucolytic uses but flags poor oral bioavailability (large acid-sensitive protein) and unmet need for safety and mechanism data.
10 sources cited · 10 verified Search all studies on PubMed ↗

Common questions about Serrapeptase

What is Serrapeptase used for?

Serrapeptase is most often taken for Reduce post-surgical swelling, Ease jaw stiffness (trismus), Thin and clear mucus, Anti-inflammatory adjunct. Proteolytic enzyme marketed for inflammation, swelling and pain.

Does Serrapeptase work — what does the evidence say?

Mixed evidence. Conflicting results across studies; benefit uncertain. Serrapeptase is a proteolytic enzyme originally isolated from silkworm-gut bacteria (Serratia) and sold as an enteric-coated supplement for inflammation, swelling and mucus. Small randomized trials show some real but narrow effects: after impacted third-molar surgery it improved jaw opening and swelling versus placebo, and a 2023 meta-analysis of six trials confirmed a benefit for trismus but not for pain or swelling. Older RCTs report less breast engorgement (about 86% vs 60% improved) and thinner, more easily cleared sputum in chronic airway disease. Head-to-head, dexamethasone outperformed it for swelling and pain, and a 2026 study found no antifibrotic benefit after liposuction. Most trials are small, short, open-label or company-linked, and oral bioavailability is uncertain because the enzyme is a large, acid-sensitive protein. A 2013 systematic review concluded the evidence is too weak to recommend it.

What is the typical dose of Serrapeptase?

Commonly 10–60 mg/day (≈20,000–120,000 SPU) as enteric-coated tablets, taken on an empty stomach in 2–3 divided doses.

Is Serrapeptase safe? Any cautions or side effects?

Generally well tolerated short-term; common effects are nausea, GI upset, skin rash and cough. Because it breaks down fibrin, it may add to bleeding risk with anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel, DOACs) and should be stopped before surgery; avoid in active abscess, as it can degrade the fibrin barrier and spread infection. Rare but serious reports include eosinophilic pneumonitis, bullous skin reactions and hemorrhage; long-term safety data are lacking and it is not recommended in pregnancy or breastfeeding given limited evidence.

How many studies support Serrapeptase?

NutriDex cites 10 sources for Serrapeptase, graded "Mixed".

Does Serrapeptase interact with any medications?

Yes — known or theoretical interactions include: Blood thinners (warfarin, DOACs) (caution), Antiplatelet drugs (aspirin, clopidogrel) (caution). This is educational and not exhaustive; always check with your doctor or pharmacist before combining Serrapeptase with any medicine.

Cite this page
APA

Peh, D. (2026). Serrapeptase (Serratiopeptidase): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 26 Jun 2026, from https://nutridex.info/s/serrapeptase

BibTeX
@misc{nutridex_serrapeptase,
  author       = {Peh, Daryl},
  title        = {Serrapeptase (Serratiopeptidase): Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/serrapeptase},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-06-26}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances